Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Johnson & Johnson (JNJ)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 337,642,944
  • Shares Outstanding, K 2,682,900
  • Annual Sales, $ 76,450 M
  • Annual Income, $ 1,300 M
  • 36-Month Beta 0.74
  • Price/Sales 4.42
  • Price/Cash Flow 13.17
  • Price/Book 5.34

Price Performance

See More
Period Period Low Period High Performance
1-Month
120.11 +4.78%
on 07/02/18
130.54 -3.59%
on 07/17/18
+3.81 (+3.12%)
since 06/20/18
3-Month
118.62 +6.10%
on 05/29/18
130.54 -3.59%
on 07/17/18
-0.81 (-0.64%)
since 04/20/18
52-Week
118.62 +6.10%
on 05/29/18
148.32 -15.15%
on 01/17/18
-10.72 (-7.85%)
since 07/20/17

Most Recent Stories

More News
Pharma Stock Roundup: JNJ & NVS' Q2 Earnings, FDA Approvals

J&J (JNJ) and Novartis (NVS) kick off earnings for pharma sector on a strong note. FDA approves J&J's latest HIV medicine and line extension of Pfizer's prostate cancer drug.

JNJ : 125.85 (-0.07%)
MRK : 62.52 (+0.02%)
LLY : 88.47 (-1.07%)
NVS : 82.27 (+1.82%)
ABBV : 88.91 (-1.16%)
RHHBY : 29.4700 (+1.94%)
PFE : 37.33 (-0.08%)
Dow 30 Stock Roundup: Goldman Sachs, IBM, J&J, Microsoft Earnings Impress

The index posted impressive gains this week, boosted by a strong economy and expectations of robust earnings.

MSFT : 106.27 (+1.79%)
IBM : 146.35 (-1.94%)
JPM : 111.28 (+1.26%)
JNJ : 125.85 (-0.07%)
WBA : 64.98 (+0.08%)
UTX : 130.26 (-0.08%)
AXP : 100.15 (-0.02%)
TRV : 125.20 (+0.02%)
GS : 231.69 (+0.90%)
AMZN : 1,813.70 (+0.04%)
UNH : 252.70 (-0.09%)
Johnson & Johnson and General Motors: Growth and Income Stocks

This week I discuss two companies within the Income Investor portfolio; Johnson & Johnson (JNJ) and General Motors (GM).

GM : 39.40 (+0.23%)
JNJ : 125.85 (-0.07%)
Free Research Report as Johnson & Johnson's Quarterly Earnings Advanced 14.75%

LONDON, UK / ACCESSWIRE / July 19, 2018 / If you want access to our free earnings report on Johnson & Johnson (NYSE: ) ("JNJ""), all you need to do is sign up now by clicking the following link . The Company...

JNJ : 125.85 (-0.07%)
Interpublic's Weber Shandwick Acquires Social Agency That Lot

Interpublic's (IPG) Weber Shandwick acquires That Lot to boost its multi-platform capabilities and expand client base globally.

IPG : 21.48 (-1.69%)
JNJ : 125.85 (-0.07%)
IHG : 65.38 (+0.65%)
HSBC : 47.38 (+0.51%)
J&J's Darunavir-Based Single-Tablet HIV Regimen Gets FDA Nod

The FDA approves Johnson and Johnson's (JNJ) darunavir-based single-tablet regimen, Symtuza, for the treatment of type 1 HIV-1 in treatment-naive and certain virologically suppressed adults.

ILMN : 311.15 (+0.66%)
JNJ : 125.85 (-0.07%)
GILD : 77.37 (+0.42%)
GSK : 41.87 (+2.90%)
Healthcare ETFs in Focus Following JNJ Q2 Results

Investors should closely watch the movement of the Johnson & Johnson and keep a close eye on ETFs having double-digit allocation to this diversified drug maker.

XLV : 86.76 (-0.20%)
VHT : 165.79 (-0.24%)
JNJ : 125.85 (-0.07%)
IHE : 157.58 (-0.35%)
IYH : 185.58 (-0.16%)
IEIH : 25.78 (+0.12%)
Stock Market News For Jul 18, 2018

Markets closed sharply higher on Tuesday, led by a rally in tech stocks.

NFLX : 361.05 (-0.87%)
UAL : 80.91 (+0.40%)
GOOGL : 1,197.88 (-0.10%)
JNJ : 125.85 (-0.07%)
CSX : 69.46 (+0.45%)
FB : 209.94 (+0.89%)
AMZN : 1,813.70 (+0.04%)
US optimism pushes stock markets mostly higher

SINGAPORE (AP) — World markets mostly rose Wednesday, spurred by the U.S. Federal Reserve's positive assessment of the U.S. economy and signs that industrial production is steady.

JNJ : 125.85 (-0.07%)
SCHW : 52.15 (-1.38%)
Healthcare ETFs in Focus Following JNJ Q2 Results

Investors should closely watch the movement of the Johnson & Johnson and keep a close eye on ETFs having double-digit allocation to this diversified drug maker.

XLV : 86.76 (-0.20%)
VHT : 165.79 (-0.24%)
JNJ : 125.85 (-0.07%)
IHE : 157.58 (-0.35%)
IYH : 185.58 (-0.16%)
IEIH : 25.78 (+0.12%)

Barchart Technical Opinion

The Barchart Opinion rating is a Hold. Short term, the outlook is Falling.

See More Share

Trade JNJ with:

Business Summary

Johnson & Johnson is engaged in the research and development, manufacture and sale of a range of products in the healthcare field. The Company operates in three segments: Consumer, Pharmaceutical, and Medical Devices and Diagnostics. Its Consumer segment offers products for use in the baby care, skin...

See More

Key Turning Points

2nd Resistance Point 126.72
1st Resistance Point 126.29
Last Price 125.85
1st Support Level 125.27
2nd Support Level 124.68

See More

52-Week High 148.32
Fibonacci 61.8% 136.97
Fibonacci 50% 133.47
Fibonacci 38.2% 129.97
Last Price 125.85
52-Week Low 118.62

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
New Chart Menu
Right-click anywhere on the chart to open the Interactive Chart menu.

Free Barchart Webinar